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Early Prediction of Outcome of Activities of Daily Living
After Stroke
A Systematic Review
Janne M. Veerbeek, MSc; Gert Kwakkel, PhD; Erwin E.H. van Wegen, PhD;
Johannes C.F. Ket; Martijn W. Heymans, PhD
Background and Purpose—Knowledge about robust and unbiased factors that predict outcome of activities of daily living
(ADL) is paramount in stroke management. This review investigates the methodological quality of prognostic studies in the
early poststroke phase for final ADL to identify variables that are predictive or not predictive for outcome of ADL after stroke.
Methods—PubMed, Ebsco/Cinahl and Embase were systematically searched for prognostic studies in which stroke patients
were included 2 weeks after onset and final outcome of ADL was determined 3 months poststroke. Risk of bias
scores were used to distinguish high- and low-quality studies and a qualitative synthesis was performed.
Results—Forty-eight of 8425 identified citations were included. The median risk of bias score was 17 out of 27 (range,
6–22) points. Most studies failed to report medical treatment applied, management of missing data, rationale for
candidate determinants and outcome cut-offs, results of univariable analysis, and validation and performance of the
model, making the predictive value of most determinants indistinct. Six high-quality studies showed strong evidence for
baseline neurological status, upper limb paresis, and age as predictors for outcome of ADL. Gender and risk factors such
as atrial fibrillation were unrelated to this outcome.
Conclusions—Because of insufficient methodological quality of most prognostic studies, the predictive value of many
clinical determinants for outcome of ADL remains unclear. Future cohort studies should focus on early prediction using
simple models with good clinical performance to enhance application in stroke management and research. (Stroke.
2011;42:1482-1488.)
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Stroke recovery is heterogeneous in terms of outcome, andit is estimated that 25% to 74% of the 50 million stroke
survivors worldwide require some assistance or are fully
dependent on caregivers for activities of daily living (ADL)
after stroke.1 In addition to medical management after acute
stroke to prevent further cerebral damage, stroke rehabilita-
tion is initiated early with the ultimate goal of achieving
better recovery in the first months after stroke and reducing
disability during the years that follow.2 The current trend to
shorten the length of stay in hospital stroke units and the
increasing demand for efficiency in the continuum of stroke
care imply that knowledge about the prognosis for outcome in
terms of basic ADL, such as dressing, mobility, and bathing,
is crucial to optimize stroke management in the first months.
In addition, it guides realistic goal-setting, enables early
discharge planning, and correctly informs patients and rela-
tives. This knowledge is also important for adequately de-
signing future trials in stroke rehabilitation. In particular,
identifying subgroups of patients who may benefit most from
a particular intervention3 and stratifying patients into prog-
nostically comparable groups4 will prevent underpowered
studies (ie, type II error), especially because the effects of
stroke rehabilitation are relatively small when compared to
the prognostic variability across included patients.5,6
Unfortunately, prognostic models have not gained much
acceptance in clinical practice due to doubts about their
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predictive accuracy because of issues such as observation
bias, problems with generalization of results, and the com-
plexity of algorithms that hamper practical implementation.7,8
Previous systematic reviews have shown that a high propor-
tion of prognostic studies in stroke is methodologically
poor.7,8 However, the most recent review of this topic dates
back to March 2002.9 Since the past decade, emphasis is
given to improve prognostic research by developing guide-
lines for the reporting of prognostic studies in health
care.10–12
The purpose of the present systematic review was to
investigate the methodological quality of prognostic studies
in the early poststroke phase for outcome of ADL and to
identify early clinical factors that are predictive or not
predictive for outcome of basic ADL beyond 3 months.
Materials and Methods
Study Identification
The following databases were searched for relevant studies by 2
researchers (J.V. and J.K.) from inception to October 2010: PubMed
(October 18), Ebsco/Cinahl (October 12) and Embase (October 19).
The following terms were used (with synonyms and closely related
words): “cerebrovascular accident” or “stroke,” and “activities of
daily living” or “walking” or “gait” or “mobility,” and “progno-
sis”10–13 or “systematic review” or “meta-analysis.” The search
strategies in the electronic databases and the full logbook of all the
searches are available on request. Studies were included when: (1)
they aimed to identify prognostic studies and combined at least 2
separate variables that were used to predict the future outcome in
individuals;3,13 (2) stroke patients aged 18 years or older had been
recruited within 2 weeks after onset. In accordance with the World
Health Organization, stroke was defined as “rapidly developing
clinical symptoms and/or signs of focal, and at times global, loss of
cerebral function, with symptoms lasting more than 24 hours or
leading to death, with no apparent cause other than that of vascular
origin.”14 Transient ischemic attacks (ICD-10 G45) and subarach-
noidal bleeding (ICD-10 I60) were excluded; (3) they were designed
as a longitudinal cohort study, which tracks a specific group of
people in time from exposure to outcome to identify incidence,
natural history, and prognosis of a disease;15 (4) they had final
outcome defined as basic ADL measured at least 3 months after
stroke and included the ability to perform basic activities of self-care
and mobility. These activities are captured by a combination of codes
d510 (washing oneself), d530 (toileting), d550 (eating), d540 (dress-
ing), b5253 (fecal continence) and b6202 (urinary continence), d410
(changing basic body position), d420 (transferring oneself), and
d450 (walking) from the International Classification of Function-
ing, disability and health;16 (5) the article was written in English,
German, French, or Dutch, because these are the most common
languages in peer-reviewed journals.17 Reference lists were
checked for other relevant studies or reviews and personal
bibliographies were consulted.
Data Abstraction
One reviewer (J.V.) extracted relevant characteristics of each cohort
study with respect to numbers recruited, timing of initial and final
observations, outcomes used, included and excluded variables for
multivariable modeling, and model performance.
Quality Appraisal
The methodological quality of reports of prognostic studies was
assessed by a developed 27-item checklist that addressed 6 major
risks of bias: study participation, study attrition, predictor measure-
ment, outcome measurement, statistical analysis, and clinical perfor-
mance/validity.7,8,10,18 As shown in Supplemental Table I (http://
stroke.ahajournals.org), each item was graded positive (sufficient
information: low risk of bias, 1 point assigned), negative (sufficient
information: potential risk of bias, 0 points assigned), or partial/
unknown (insufficient information: ? assigned). A total score was
obtained by summing all items that were scored as positive. This list
was pilot-tested on 3 different prognostic studies that did not meet
the study inclusion criteria to reach consensus about each checklist
item. A priori, we considered a study to be at low risk for bias when
it scored 20 points (75% of the maximum score)8 and at high risk
for bias when it scored 19 points. Two reviewers (J.V. and M.H.)
independently assessed the risk of bias of the included studies. They
were not blinded to author names, institutions, or journal of publi-
cation. Disagreements were resolved in a consensus meeting.
Analysis
We were unable to perform a quantitative analysis (statistical
pooling) of the data because of heterogeneity in terms of study
design, moment of inception and follow-up, and the composition and
analytical methods of the multivariable models. Consequently, a
best-evidence synthesis was performed independently by J.V. and
E.W. to summarize the findings of the included studies. Based on the
number, quality (ie, low- or high-risk of bias), and results of these
cohort studies, 4 levels of evidence for a particular predictor variable
were distinguished: (1) strong evidence: generally consistent find-
ings in multiple (2) studies with low risk of bias; (2) moderate
evidence: generally consistent findings in 1 study with low risk of
bias and1 studies with high risk of bias; (3) limited evidence: only
1 study with low risk of bias is available; and (4) insufficient or no
evidence: consistent findings in multiple studies with high risk of
bias, inconsistent findings in multiple studies, inconsistent findings
within 1 study, or no significant result with outcome of interest is
present.19,20
Generally consistent findings means that the number of studies
showing evidence was 50% of the total number of studies within
the same methodological quality category. Otherwise, insufficient or
no evidence was allocated. Subsequently, predictors and nonpredic-
tors were classified according to the International Classification of
Functioning Disability and Health in terms of body structures, body
functions, activities and participation, and personal and environmen-
tal factors.
Results
Study Identification
The Figure shows that the electronic search resulted in 8425
citations. On the basis of this search and checking references,
a total of 48 studies were included.21–71 Contacting authors for
further information did not result in additional inclusions. A list
of excluded studies can be obtained from the corresponding
author on request.
Study Characteristics
A description of the main characteristics of the included
prognostic studies can be found in Supplemental Table II.
The number of participants in the 48 inception cohorts
ranged from 4134 to 4499,64 and amounted to a total of
25 843 subjects. Forty-two of the 48 studies recruited
immediately after hospital admission (ie, hospital-
based).21–26,29,31,32,34 – 40,42,44 –54,56 –59,61,62,64 –71 Twenty-one
studies included patients with ischemic and hemorrhagic
strokes,21,27a,30,31,33,35,38,39,41,46,49,52,58,62–67,69,70 whereas 13 studies
were restricted to first-ever strokes.22,29–31,37,41,45,48,50,53,64,66 The
mean time that had elapsed between stroke onset and initial
observation was 5.4 days, ranging from 136.6 minutes48 to 14
days.33,38,44,52 All studies defined final outcome of ADL at
a fixed moment after onset, with the exception of two.45,69
Some studies used 1 ADL measurement in their
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prognostic investigations.23,42,61 The Barthel Index (BI;
K24) 23,24,26,29,31,32,34,37,41,42,45,46,51–53,58–62,64–66,68 was the most
frequently used scale to assess ADL outcome, followed by the
modified Rankin scale (K18),21–23,25,30,35,37,38,42,44,47,49,50,57,67,70,71
the Glasgow Outcome scale (K4),40,42,56,61 the Functional
Independence Measure (K2),38,54 the Oxford Handicap
Scale (K1),27a the Katz scale (K1),63 and other less known
ADL assessment instruments (K2).39,69 Thirty-six studies
dichotomized21–26,27a,29–33,35–37,40,42–51,53,56,59–62,64,65 or cla-
ssified41,58 outcome of ADL, with cut-off scores ranging
from 6023,42 to 95,23,24,26,33,42,45,62 for the 100-point version
of the BI, and from 1259,65 to 1929 for the 20-point BI
version. The modified Rankin scale cut-off scores varied
from 123,37,42 to 5.23
Quality Appraisal
As shown in Supplemental Table III (http://stroke.ahajournals.
org), the median risk of bias scores of the included studies
was 17 points (range, 671–2221,22). Six of the 48 studies were
of high methodological quality and scored 20 out of 27
available points.21–26
Study Design
Eighty-three percent of the included studies clearly stated the
inclusion and exclusion criteria, and 48% described baseline
key characteristics of the study sample. A prospective design
was used in 77% of the studies. Twenty-seven percent gave
information about the medical or paramedical treatment
provided.
Study Attrition
The number lost to follow-up was reported in 77% of the
articles, reasons were stated in 67%, and adequate methods of
dealing with missing data were described in 33% of the
studies.
Predictor Measurement
Predictors were well-defined in 92% of the studies, but only
19% reported a clear rationale for the cut-off scores that were
used.
Outcome Measurement
The outcome was clearly defined in 96% of the studies, and
42% properly defined both cut-off points and rationale.
Statistical Analysis
All studies reported whether they used linear or logistic
regression techniques; however, 38% gave information about
variable selection methods and the probability value used for
acceptance. Univariable crude estimates and confidence in-
tervals were described in 19% of the studies, whereas 73%
reported point estimates with confidence intervals of the
multivariable analysis. Finally, 35% did not dichotomize
variables of a continuous nature, like age.
Clinical Performance/Validity
Clinical performance was tested in 56% of the studies using
explained variance (K9),26,34,38,45,54,57,63,69,71 area under the
curve (K7)21,23–25,27a,29,42 or c-statistic (K1),57 overall
accuracy (K6),22,26,29,31,39,59 sensitivity and specificity
(K5),22,32,41,44,59 Hosmer-Lemeshow statistic (K2),36,44
and calibration (K1),23 whereas 1 study just reported the
graph of the receiver-operating characteristic curve.68 The
model developed was internally validated in 8% and exter-
nally validated in 21% of the studies.
Identified Early Poststroke Predictors of
Final Outcome
Six studies showed a low risk of bias and 42 studies a high
risk of bias. The Table shows the predictor variables mea-
sured early after stroke with their level of evidence, that were
predictive for outcome of ADL 3 months.
Strong evidence was found for patients’ neurological status
measured with the National Institutes of Health Stroke Scale
(NIHSS) or the Canadian Neurological Scale, with items
relating to lower severity of (upper limb) paresis as strong
components for better outcome of ADL. In addition, strong
evidence was found for older age as a variable disfavoring
outcome of ADL. Supplemental Table IV (http://stroke.
ahajournals.org) lists those variables that were found not to be
predictive for outcome of ADL 3 months. Synthesis re-
sulted in strong evidence that gender and risk factors, such as
atrial fibrillation, are unrelated to final outcome of ADL 3
months.
Discussion
Prediction plays an important role in evidence-based clinical
decision-making after stroke by objectifying, simplifying,
and increasing the accuracy of forecasting patients’ future
functioning.72 The present research synthesis investigated
which early measured variables are predictive or not predic-
tive for basic ADL outcome after stroke. A vital aspect herein
is the assessment of methodological quality. The large num-
ber of studies published in the past decade shows that
prognosis in stroke rehabilitation is a growing field of
Figure. Flow diagram of literature search.
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interest. However, prognostic research is complex, acknowl-
edging that the generalization is mostly limited. Because of
methodological shortcomings and inadequate reporting, the
predictive value of most determinants for outcome of ADL
after stroke is indistinct. It should be acknowledged, however,
that the development of the methodology of prognostic
studies is still in progress10 and that the guidelines for
reporting observational studies according to the Strengthen-
ing of Reporting of Observational Studies in Epidemiology
(STROBE) statement only recently have been established.12
Fortunately, our review shows a positive evolution of the
Table. Best-Evidence Synthesis of Early Measured Variables
Predictive for Outcome of Activities of Daily Living >3 Months
After Stroke According to the International Classification of
Functioning, Disability and Health
Variable Level of Evidence
Body structures
Stroke classification IV
Imagine variables
Stroke volume IV
Focal computed tomography abnormality III
Leukoaraiosis III
Superficial middle cerebral artery IV
Cortical IV
Posterolateral extension involving posterior
limb of internal capsule
IV
Location (lobar, deep, infratentorial) IV
Lenticulostriate arteries infarction III
NIHSS*small vessel occlusion IV
Days to magnetic resonance imaging IV
Intima-media thickness IV
Body functions
Initial neurological status I
GCS verbal IV
Able to talk and oriented IV
Paresis IV
Arm I
Grip strength IV
Tendon reflexes IV
Able to swallow IV
Cognitive deficit* IV
Dysphasia IV
Complications
Neurological complications III
Fever III
Orpington prognostic score IV
Allen prognostic score IV
Activity and participation
Trunk control test IV
Gait
Ability to walk IV
Able to walk unaided II
ADL functioning IV
Change in ADL at days 2–15 IV
Disability III
Leg function IV
Personal factors
Age I
Prestroke independence II
Prestroke mobility IV
Comorbidity and risk factors
No. of risk factors IV
Previous stroke II
(Continued)
Table. Continued
Variable Level of Evidence
Neurological impairment IV
Diabetes IV
Hypertension IV
Myocardial infarction IV
Heart failure IV
Cognitive impairment IV
Depression IV
Cardiac, blood, and urine variables
Urea IV
CFU-EC increment, week 1 IV
Living alone IV
Relationship with significant other IV
Previous Short Form-36 health survey IV
Prestroke institutionalization IV
Educational level IV
Prestroke financial security IV
Nutrition
Malnutrition IV
Undernourished IV
Undernutrition, week 1 IV
Race IV
Black*time IV
Environmental factors
Time from onset IV
Time (log function) IV
Discharge to nursing home or other institution IV
Inpatient treatment neurologist IV
Days to rehabilitation initiation IV
Black*days to rehabilitation*time IV
Days to rehabilitation*time IV
Adequacy of home and neighborhood IV
I, strong evidence: generally consistent findings in multiple (2) studies with
low risk of bias. II, moderate evidence: generally consistent findings in 1 study
with low risk of bias and1 studies with high risk of bias. III, limited evidence:
only 1 study with low risk of bias is available. IV, insufficient or no evidence:
consistent findings in multiple studies with high risk of bias, inconsistent
findings in multiple studies, inconsistent findings within 1 study, or no
significant result with outcome of interest is present.
ADL indicates activites of daily living; CFU-EC, colony-forming unit-endo-
thelial cell; GCS, Glasgow coma scale; NIHSS, National Institutes of Health
Stroke Scale.
*eg, neglect, dyspraxia, visuospatial problems.
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methodological quality of prognostic studies because 5 out of
the 6 high-quality studies were published in the past decade.
This illustrates the growing awareness among investigators
that they have to meet the methodological criteria for predic-
tion model development.
Despite the fact that only a small proportion (12.5%) of the
included studies were of high quality, we found strong
evidence that age and outcomes assessing severity of neuro-
logical deficits in the early poststroke phase, such as the
NIHSS23,25,73 and Canadian Neurological Scale,22 are highly
associated with final basic ADL outcome beyond 3 months
after stroke. More specifically, items related to severity of
motor impairments seem to be the most important compo-
nents of these scales for predicting outcome of ADL. These
findings are largely in line with Counsell et al,7 who reported
these multivariable tested predictors for the outcome in terms
of survival in an independent state. In addition, there is strong
evidence that gender and the presence of risk factors for
stroke, such as atrial fibrillation, do not predict outcome of
basic ADL. The present systematic review also shows that the
added value of imaging data for the prediction of ADL
outcome is limited when compared to the contribution of
clinical variables alone.21,29,74
Just as in stroke trials, the BI and modified Rankin scale
were the two activity-level outcome measures most fre-
quently used in prognostic stroke studies.75 Both outcomes
were dichotomized for regression analysis in many studies,
although cut-off points varied. For example, “independent” or
“favorable” on the BI was defined as either 60, 85, 90,
95, or 95, hampering a valid comparison across the
included studies. The comparability of studies can be im-
proved by using well-established cut-off points.76 Remark-
ably, the Functional Independence Measure, which is com-
monly used to evaluate outcome in terms of ADL dependency
after stroke,77 has barely been used in inception cohorts
started from stroke onset (ie, within 2 weeks) for the purpose
of making predictions beyond 3 months.38,54
Unfortunately, prognostic models are not commonly ap-
plied in routine care for a number of reasons. First, successful
clinical implementation of the investigated models is ham-
pered by the complexity of the algorithms derived from them.
Second, opportunities to generalize the probabilities of de-
rived models are limited because of differences in patient
characteristics. The cohorts in the prognostic studies included
in our review were often mixed but sometimes restricted to,
for example, ischemic or hemorrhagic strokes, or anterior
circulation or posterior circulation infarcts. Obviously, the
selection of a cohort with a common underlying stroke type
increases the precision with which the outcome of interest can
be predicted but limits its generalization to other stroke types.
This suggests that transparency is needed concerning the
criteria used for patient selection. In addition, case-mix
adjustment has to be considered to control for differences in
sample recruitment. Third, generalization of the probabilities
of existing models based on clinical and imaging variables is
hampered by differences in the timing of clinical determinant
measurement in the early poststroke phase.6,73,78 For example,
in a recent cohort study we found that the earliest time at
which an optimal prediction of ADL independency outcome
(ie,19 points according to the BI) could be made was at day
5 after stroke, whereas day 2 scores resulted in suboptimal
prediction because of an underestimation of patients’ abilities
when they are still bed-ridden.78 In contrast, the accuracy of
the NIHSS in predicting ADL outcome is almost unaffected
by the timing of assessment in the first 9 days after stroke,
making this instrument more robust for determining patient
prognosis.73 Finally, prediction models still misclassify a
certain amount of patients, but most prognostic studies failed
to report information about the performance of the model
derived and also failed to verify its internal and external
validity, which is important because prediction rules are
always less accurate when retested in an independent patient
cohort.8,79
The present review does have some limitations. First,
despite a sensitive search, publications may have been missed
because of poor indexation of the literature reporting obser-
vational studies including prognostic research.80 Second, data
extraction was performed by 1 reviewer.81 Third, the scoring
list for the assessment of methodological quality was based
on recent recommendations for prognostic research as well as
criteria used in previous scoring lists for assessment of
prognostic stroke research.10,18 However, there may be room
for improvement because the development of criteria for
assessing methodological quality is still in progress. For
example, the used criteria for defining study characteristics
such as an inception cohort (ie, 2 weeks) and final outcome
(ie, 3 months) are based on purely pragmatic grounds.
A future overview of unbiased predictors of ADL outcome
will only be possible when the key methodological criteria for
prognostic research are met. Besides, future studies should
aim for robust but clinically feasible predictors of ADL
outcome. For this, consensus about International Classifica-
tion of Functioning-linked definitions and standardized mea-
surement of these predictors is conditional. Recently, we
found in 3 cohorts of patients with a first-ever hemispheric
stroke that the baseline value of the dependent variable for
measuring ADL is highly predictive of the final out-
come.5,78,82 However, only a few low-quality studies have
investigated this relationship so far.29,31,46,59,62,66 In addition,
Stinear82 recently suggested that the accuracy of prediction
might be increased by combining simple bed-side tests of
motor impairment with neuroimaging, genotyping, and neu-
rophysiological assessment of neural plasticity. Furthermore,
patients preferably should be tested at fixed moments early
after stroke, because clinical determinants are time-dependent
and nonlinearly related with stroke recovery.6 Determining
the optimal timing for predictions requires studies with an
intensive repeated-measurement design.83 In the same vein,
new statistical methods such as random coefficient analysis52
allow one to investigate how early neurological improve-
ments may affect the accuracy of predicting final outcome
after stroke. In addition, an accurate model is of no benefit if
it is not generally applicable and is not implemented in
practice.84 This means that implementation studies are needed
to investigate the added value of using prediction rules in
daily practice for the accuracy of clinical decision-making,
compared to clinical expertise alone.84 Finally, the present
systematic review shows that more attention must be given to
1486 Stroke May 2011
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a uniform procedure in selecting and dichotomizing determi-
nants to make prognostic models comparable.75
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Table I. Quality assessment of reports of prognostic studies1-4 
OUTCOME STRATEGIES  SCALE CRITERIA 
Evaluation of 
Study design 
D1 Source population and recruitment  Y/N/? Positive when sampling frame (e.g. hospital-based, community-based, primary 
care) and recruitment procedure (place and time-period, method used to identify 
sample) are reported.  
D2 Inclusion and exclusion criteria  Y/? Positive if both the inclusion and exclusion criteria are explicit described.  
D3 Important baseline key characteristics 
of study sample  
Y/? Positive if the following key characteristics of the sample are described: gender, 
age, type, localization, number of strokes*, stroke severity.  
*Number of strokes is adequate when at least ‘a history of stroke’ or ‘recurrent 
stroke’ is reported. 
D4 Prospective design Y/N/? Positive when a prospective design was used, or in case of a historical cohort in 
which prognostic factors are measured before the outcome is determined.  
D5 Inception cohort Y/N/? Positive if observation started at a uniform time point within two weeks after stroke 
onset.  
D6 Information about treatment  Y/N/? Positive if information on treatment during observation period is reported (e.g. 
(para)medical, usual care, randomized, etc.). 
Study attrition 
A1 Number of loss to follow-up Y/N/? Positive if number of loss to follow-up during period of observation did not exceed 
20%.  
A2 Reasons for loss to follow-up Y/N/? Positive if reasons for loss to follow-up are specified, or there was no loss to follow-
up.  
A3 Methods dealing with missing data Y/N/? Positive, if in case of missing values the method of dealing with missing values is 
adequate (e.g. multiple imputation), or there are no missing values.  
A4 Comparison completers and non-
completers  
Y/N/? Positive if article mentions that there are no significant differences between 
participants who completed the study and who did not, concerning key 
characteristics gender, age, type and severity and candidate predictors and 
outcome, or there was no loss to follow-up.  
Predictor measurement 
P1 Definition of predictors Y/? Positive if the article clearly defines or describes all candidate predictors 
(concerning both clinical and demographic features).  
P2 Measurement of predictors reliable 
and valid 
Y/N/? Positive if ≥1 candidate predictors are measured in a valid and reliable way, or 
referral is made to other studies which have established reliability and validity. 
P3 Coding scheme and cut-off points Y/N/? Positive if coding scheme for candidate predictors were defined, including cut-off 
points and rationale for cut-off points was given; or if there was no dichotomization 
or classification.  
P4 Data presentation Y/N/? Positive if frequencies or percentages or mean (SD/CI), or median (IQR) are 
reported of all candidate predictors.  
Outcome measurement 
O1 Outcome(s) defined Y/N/? Positive when a clear definition of the outcome(s) of interest is presented.  
O2 Measurement of outcome(s) reliable 
and valid 
Y/N/? Positive when outcome is measured in a valid and reliable way, or there is referred 
to other studies which have established reliability and validity. 
O3 Coding scheme and cut-off points 
described 
Y/N/? Positive if coding scheme of the outcome was defined, including cut-off points and 
rationale for cut-off points was given; or if there was no dichotomization.  
O4 Appropriate end-points of observation Y/N/? 
 
Positive if observation was obtained at a fixed moment after stroke onset, negative 
when observation was obtained at discharge. 
O5 Data presentation Y/N/? Positive if frequencies or percentages or mean (SD/CI) or median (IQR) are 
reported of the outcome measure.  
 Statistical analysis  
S1 Strategy for model building described Y/N/? Positive if the method of the selection process for multivariable analysis is 
presented (e.g. forward, backward selection, including p-value).  
S2 Sufficient sample size Y/N/? Positive if in logistic regression analysis number of patients with a positive or 
negative outcome (event) per variable is adequate, i.e. is equal to or exceeds 10 
events per variable in the multivariable model (EPV), or in case of linear regression 
analysis, N is ≥100.  
S3 Presentation univariable analysis Y/N/? Positive if univariable crude estimates and confidence intervals (β/SE, OR/CI, RR, 
HR) are reported. Negative when only p-values or correlation coefficients are given, 
or if no tests are performed at all. 
S4 Presentation multivariable analysis Y/N/? Positive if for the multivariable models point estimates with confidence intervals 
(β/SE, OR/CI, RR, HR,) are reported. 
S5 Continuous predictors Y/N/? Positive if continuous predictors are not dichotomized in the multivariable model.  
Clinical performance/validity  
C1 Clinical performance  Y/? Positive if article provides information concerning ≥1 of the following performance 
measures: discrimination (e.g. ROC), calibration (e.g. HL statistic), explained 
variance, clinical usefulness (e.g. sensitivity, specificity, PPV, NPV) 
C2 Internal validation Y/? Positive if appropriate techniques are used to assess internal validity (e.g. cross-
validation, bootstrapping), negative if split-sample method was used. 
C3 External validation  Y/? Positive if the prediction model was validated in a second independent group of 
stroke patients.  
Y, Positive, 1 point; N, Negative, 0 points; ?, Partial/unknown 
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2004;144:427-437. 
2. Counsell C, Dennis M. Systematic review of prognostic models in patients with acute stroke. Cerebrovasc Dis. 
2001;12:159-170. 
3. Kwakkel G, Wagenaar R, Kollen B, Lankhorst G. Predicting disability in stroke -- A critical review of the literature. Age 
Ageing. 1996;25:479-489. 
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Table II. Characteristics of included prognostic studies 
First author 
year 
 
N Stroke 
specification 
Sampling 
frame, 
mean time 
poststroke 
at 
inclusion  
Follow-up 
poststroke 
Outcome Prognostic variables in 
final model in hierarchical 
order (cut-off point) 
 
Variables excluded in 
multivariable analysis 
Model 
performance 
Reid 
2010 
538 
 
Ischemic, 
hemorrhagic 
H, ? 6 mos mRS ≤2 Model 1, clinical variables 
Pre-stroke independence * 
Arm power * 
Age 
Stroke severity score 
 
Model 2, clinical variables, 
excluding stroke severity 
Pre-stroke independence * 
Arm power *  
GCS verbal * 
Able to walk unaided * 
Age 
 
 
 
Model 3, CIVIC and clinical 
variables 
Pre-stroke independence * 
Arm power * 
Age 
Leukoaraiosis score 
Stroke severity score 
Focal CT abnormality * 
 
Gender  
Prior stroke/TIA 
Atrial fibrillation  
Presenting <3 hours 
TACI 
LACI 
Posterior circulation 
stroke 
Hemorrhagic stroke 
Left hemisphere 
Infratentorial localization 
Dysarthria 
GCS verbal 
Walk without assistance 
rTPA treatment 
 
Any abnormality 
Mean number focal 
lesions 
Acute infarct present 
Acute infarct or 
hemorrhage 
 
AUC 0.882 
 
 
 
 
 
AUC 0.826 
 
 
 
 
 
 
 
 
 
AUC 0.901 
Fiorelli  
1995 
300 Ischemic, 
first-ever 
hemispheric 
H, <6 hours 4 mos (modified) 
mRS ≥3  
CNS admission (≥7, 5-6.5, 
≤4.5) 
Age (≤70, >70) 
Atrial fibrillation 
Gender 
 
Risk cut-off 
0.60:  
Acc 0.78 
Sens 0.61 
Spec 0.84 
 
Johnston 
2007 
382 
 
Ischemic H, <24 
hours 
3 mos BI ≥95 
 
 
 
 
 
BI ≤60 
 
 
 
 
 
mRS <2 
 
 
 
 
 
mRS ≥5 
 
 
 
rTPA treatment * 
DWI stroke volume 
Age 
NIHSS baseline 
Diabetes * 
 
rTPA treatment * 
NIHSS baseline 
Age 
DWI stroke volume 
Time to DWI 
 
Age 
DWI stroke volume 
NIHSS baseline 
 
 
 
NIHSS baseline 
Age 
DWI stroke volume 
Pre-stroke disability 
TimeDWI stroke 
volume 
 
 
 
Pre-stroke disability 
TimeDWI stroke 
volume 
Diabetes 
 
 
Pre-stroke disability 
TimeDWI stroke 
volume 
Diabetes 
rTPA treatment 
 
Pre-stroke disability 
TimeDWI stroke 
volume 
Diabetes 
rTPA treatment 
 
AUC 0.803 
Calibration 
cut-off 0.4: 
MAE 0.33 
 
 
AUC 0.808 
MAE 0.24 
 
 
 
 
AUC 0.795 
MAE 0.37 
 
 
 
 
AUC 0.832 
MAE 0.15 
Weimar  
2006 
303 Hemorrhagic, 
first-ever 
H, <72 
hours 
6 mos BI ≥95 Age  
Initial NIHSS 
 
Gender 
Coronary heart disease 
Initial NIHSS 
consciousness 
Diameter bleeding 
Ventricular bleeding 
and/or hydrocephalus 
 
Cut-off -0.42 
AUC 0.861 
Sato  
2008 
310  
 
Ischemic  
 
H, <72 
hours 
3 mos mRS ≤2 Model, anterior circulation 
NIHSS admission 
 
 
 
 
Model, posterior circulation 
NIHSS admission 
Ischemic heart disease * 
 
Age 
Gender 
Ischemic heart disease 
Atrial fibrillation 
Stroke etiology (TOAST) 
 
Age 
Gender 
Atrial fibrillation 
Stroke etiology (TOAST) 
 
AUC 0.868 
(0.818-0.917) 
 
 
 
 
AUC 0.867 
(0.783-0.951) 
Weimar  
2002 
 
1754 
 
Ischemic H, <24 
hours 
100 days BI ≥95  Neurological complications * 
Fever (>38, ≤38 oC) 
Lenticulostriate arteries 
infarction * 
Diabetes * 
41 variables in total 
investigated  
R2=0.554 
Acc 0.807 
(cut-off 
0.437) 
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Ranking scale  
Prior stroke * 
Left arm weakness  
Right arm weakness  
Gender 
Age  
NIHSS admission  
 
Counsell 
2002 
530  
 
Ischemic, 
hemorrhagic 
C, 4 days 6 mos OHS <3 Model 1, simple clinical 
variables 
Independent before stroke 
(OHS ≤2, >2) * 
GCS verbal (<5, 5) * 
Arm power * 
Ability to walk * 
Living alone * 
Age 
 
 
 
Model 2, Model 1 + more 
detailed clinical variables † 
Age * 
Living alone * 
Independent before stroke * 
GCS verbal * 
Arm power * 
Ability to walk * 
Current smoker * 
Cognitive deficit * 
 
 
Model 3, Model 1 + 2 + 
investigation results † 
Age  
Living alone * 
Independent before stroke * 
GCS verbal * 
Arm power * 
Ability to walk * 
Current smoker * 
Cognitive deficit * 
Urea (≤7 mmol/L) 
 
Gender 
Employed 
Hypertension 
Myocardial infarction 
Diabetes 
Malignancy 
Examined <2 days 
Systolic blood pressure 
GCS eye 
GCS motor 
Able to lift legs 
 
Previous TIA 
Peripheral vascular 
disease  
Apoplectic onset 
Cervical bruit 
Cardiac disease 
Dysphasia 
Visual field defect 
Gaze palsy 
Brain stem function  
Proprioception 
 
High hemoglobulin level 
Anemia 
Platelet count 
Glucose 
Atrial fibrillation 
Abnormal cardiac rhythm 
AUC (SE) 
0.839 (0.017) 
 
 
 
 
 
 
 
 
 
 
AUC (SE) 
0.829 (0.017) 
 
 
 
 
 
 
 
 
 
AUC (SE) 
0.853 (0.023) 
Schiemanck 
2006 
75 
 
Ischemic, 
MCA, first-
ever 
H, 11 days 1 yr BI ≥19 Model 1, clinical variables 
Initial BI (>9, ≤9) 
Age 
 
Model 2, clinical and MRI 
variables 
Initial BI (>9, ≤9) 
Lesion volume (≤22 mL, >22 
mL) 
Hemisphere (left, right) 
Age 
Days poststroke to MRI scan  
 
Gender  
Educational level (high/ 
low) 
Relationship * 
NIHSS 
MI (>100, ≤100) 
Urinary incontinence 
Sitting balance * 
AUC 0.84 
Acc 0.77 
 
 
AUC 0.87 
Acc 0.83 
Appelros 
2003 
377 Ischemic, 
hemorrhagic, 
first-ever 
C, <48 
hours 
1 yr mRS ≥3 Heart failure *  
NIHSS 
Age 
Gender 
Hypertension 
Diabetes 
Ischemic heart disease 
TIA 
Peripheral 
atherosclerosis 
 
 
Sánchez-
Blanco  
1999 
92 
 
Ischemic, 
hemorrhagic, 
first-ever, 
unilateral 
H, 11 days 6 mos BI ≥85 Stroke clinical classification 
(M, MS, MSH) 
Initial BI (>20, ≤20) 
Prior independence (limited 
activity, nonlimited) 
 
Gender 
Age 
Family support prior to 
stroke 
Acute hospital discharge 
Stroke side 
Stroke type (ischemic, 
hemorrhagic) 
Topographic stoke 
subtypes 
Consciousness at 24 
hours 
Mental status 
Visuospatial perception 
Comprehension of 
speech 
Functional expression 
Motor loss 
Sitting balance 
 
Acc 0.79 
Baird 2001 66 Ischemic, H, <48 3 mos BI ≥90 NIHSS score (≤3, 4-15, >15) Age Sens 0.77 
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 anterior 
circulation 
hours DWI lesion volume (≤14.1 
mL,>14.1 mL)  
Time from onset (≤3 h, 3< 
time ≤6 h, >6 h) 
 
Gender 
Hypertension 
Heart disease 
Participation in a drug 
trial 
 
Spec 0.71 
Lai  
2002 
459 
 
Ischemic, 
hemorrhagic 
C, <14 days 6 mos  BI ≥95 Prior SF-36 
Age  
Orpington prognostic score 
GDS (<6, ≥6) 
 
Charlson comorbidity 
index 
 
Woldag  
2006 
41 
 
Ischemic, 
supratentorial 
H, <72 
hours 
6 mos BI Model 1, admission † 
BI  
HAND  
Age 
 
Model 2, day 7 † 
NIHSS  
HAND  
Age 
Previous stroke * 
 
Disability  
NIHSS 
Prior stroke 
 
 
∆ NIHSS admission to 
day 7 
∆ HAND admission to 
day 7 
BI 
R2=0.422 
 
 
 
 
R2=0.788 
 
 
 
Acciarresi 
2006 
435 
 
Ischemic, 
hemorrhagic 
H, <72 
hours 
3 mos mRS >2 NIHSS (<15,  ≥15) 
Age 
Superficial MCA * 
Gender 
 
Atrial fibrillation 
TACI 
LACI 
Impaired consciousness 
Small vessel disease 
Cardioembolism 
Undetermined causes 
Subcortical 
Entire MCA 
 
 
Yoo  
2008 
131 Ischemic H, <24 
hours 
3 mos mRS 
responder 
analysis 
 
mRS ≤2 
 
mRS ≥3 
 
Undernutrition wk 1 * 
NIHSS wk 1 
Gender 
 
NIHSS wk 1 
 
NIHSS wk 1  
Age 
 
Cardioembolism 
Insufficient diet 
Age 
Initial NIHSS 
Initial undernutrition 
External feed 
HL-statistic 
X2=3.6 
(p=.89) 
Lee  
2009 
533 
 
Ischemic, 
first-ever 
H, <10 days 6 mos mRS <2 Diabetes * 
NIHSS admission 
Total cholesterol 
 
Serum albumin 
Fibrinogen 
Uric acid 
C-reactive protein 
Body mass index 
Gender 
Heart disease 
Complications 
 
 
Duarte  
2010 
75 
 
Ischemic, 
hemorrhagic 
H, 14 days 6 mos Motor FIM Model 1, TCT † 
Age (<64, 64-74, >74 yr) 
TCT (<37, 37-74, >74) 
 
 
Model 2, NIHSS † 
Age (<64, 64-74, >74 yr) 
NIHSS (<5, 5-10, >10) 
Gender 
 
Stroke type (ischemic, 
hemorrhagic) 
Urinary incontinence  
Gender 
 
Stroke type (ischemic, 
hemorrhagic) 
Urinary incontinence  
 
R2=0.61 
 
 
 
 
R2=0.58 
 
 
Fullerton 
1988 
206 
 
Ischemic, 
hemorrhagic 
H, <48 
hours 
 
6 mos “mRS” Weighted mental score 
ECG changes  
Leg function 
Level of consciousness 
Arm power 
Albert’s test score (neglect) 
 
Age 
Daily cigarettes 
Hematocrit 
Erythrocyte 
sedimentation rate 
Conjugate eye 
movement 
Mental score 
Speech 
Vision 
Leg power 
Walking/balance 
Arm function 
Sensation (light touch) 
Sensation 
(proprioception) 
Denial 
Disordered spatial 
orientation 
Apraxia 
Continence 
 
Acc 0.68 
Daverat 
1991 
166 
 
Hemorrhagic H, <24 
hours 
6 mos GOS ≤2 Intraventricular hemorrhage * 
Age (10-yr groups) 
Limb paresis (4 classes) 
Hemorrhage size (<10, 10-
Gender 
Hemorrhage side 
Hemorrhage location 
Oral comprehension 
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20, >30%) 
 
Oral expression 
 
Taub  
1994 
639 Ischemic, 
hemorrhagic, 
first-ever, <75 
yr 
C, ? 3 mos BI 
0-9, 10-14, 
15-19, 20 
Initial incontinence * 
Initial swallowing problems * 
Initial paralysis * 
 
Age 
Gender 
District of residence 
Ethnic origin 
Living alone before 
stroke 
Premorbid disability (BI) 
Initial coma 
Initial speech problems 
 
Sens 0.67 
Spec 0.69 
Johnston 
2000 
256 
 
Ischemic H, <1 week 3 mos BI ≥95 
 
 
 
 
 
BI <60, 
death 
 
 
 
GOS 1 
 
 
 
 
 
GOS >2 
Initial NIHSS 
Age  
Diabetes * 
Infarct volume (cm3) 
Prior disability * 
 
Prior disability * 
Infarct volume (cm3) 
Initial NIHSS 
Age  
 
Age  
Initial NIHSS 
Diabetes * 
Infarct volume (cm3) 
Prior disability * 
 
Infarct volume (cm3) 
Age 
Initial NIHSS 
 
Small vessel 
Prior stroke 
Diabetes 
 
 
 
Small vessel 
Prior stroke 
Diabetes 
 
 
Small vessel 
Prior stroke 
 
 
 
 
Small vessel 
Prior stroke 
Diabetes 
Prior disability 
 
AUC 0.84 
 
 
 
 
 
AUC 0.88 
 
 
 
 
AUC 0.84 
 
 
 
 
 
AUC 0.88 
Liu  
2007 
489 Ischemic H, <14 days 28.3 mos mRS ≤2 Age (≤60, >60 yr) 
Educational level (0-5) 
Prior stroke * 
NIHSS 
Gender 
Smoking 
Atrial fibrillation 
OCSP typing 
Complications 
 
Sens 0.77 
Spec 0.71 
HL statistic 
p=.787 
Protopsaltis 
2009 
105 
 
Ischemic, 
first-ever, 
non-embolic 
H, ? 6 mos after 
discharge 
BI >95 TACI location * 
Intima-media thickness  
Infarct volume 
 
 R2=0.363 
Shen  
2010 
483 
 
Ischemic, 
hemorrhagic, 
>50 yr 
H, <48 
hours 
6 mos BI <75 Malnutrition * 
NIHSS admission 
Age 
 
Complications 
Length of hospital stay 
Stroke type (ischemic, 
hemorrhagic) 
Renal failure 
BI admission 
Gender 
 
 
Franke  
1992 
157 Hemorrhagic, 
supratentorial  
H, 72 hours 1 yr mRS ≥3 Age (<70, ≥70) 
GCS eye, motor day 3 (<9, 
≥9) 
mRS day 3 (>4, ≤4) 
 
Paresis 
Blood glucose levels 
Hematoma volumes 
 
Censori  
1993 
172 Ischemic, 
first-ever, 
carotid artery 
area 
 
H, 136.6 
min 
 
6 mos mRS ≤2 CNS (<6.5, ≥6.5) Atrial fibrillation 
Age 
 
FOOD 
collaboration 
2003 
3012 Ischemic, 
hemorrhagic 
H, <7 days 6 mos mRS (alive, 
independent) 
Undernourished * 
Age 
Able to talk and oriented * 
Walk without assistance * 
Able to swallow * 
Pre-stroke independent ADL 
* 
Able to lift both arms off the 
bed * 
 
Pre-stroke stroke living 
alone 
Overweight 
 
Sobrino  
2007 
48 Ischemic, 
first-ever, 
nonlancunar 
H, <12 
hours 
3 mos mRS ≤2 Colony-forming unit-
endothelial cell increment 
first week (≥4,<4) 
Initial NIHSS 
Initial ischemic volume 
 
rTPA treatment  
Misra  
1996 
69 Hemorrhagic, 
supratentorial 
H, 6.5 days 3 mos BI ≥12 GCS 
CNS 
Reflex (hypo, hyper, normal) 
Ventricular extension * 
MEP * 
 
Medical complications 
Incontinence 
 
 
Tilling  
2001 
299 
 
Ischemic, 
hemorrhagic 
H, <14 days <2, 4, 6, 12 
mos 
BI Pre-stroke disability * † 
Urinary incontinence * 
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Dysarthria * 
Gender 
Age 
Dysphasia * 
Limb deficit baseline * 
 
Ellul  
2004 
284 Ischemic, 
first-ever 
H, <7 days 1 yr BI ≤15 Pre-stroke mRS 
Age (5-yr groups) 
Initial SSS (5-points) 
 
Gender 
Hypertension 
Diabetes 
Atrial fibrillation 
Ischemic heart disease 
Hypercholesterolemia 
Current smoking 
Side of lesion 
Site/extend lesion 
Carotid stenosis 
CCA-IMT 
 
 
Hinkle  
2006, 2010 
100 
 
 
? 
 
H, <72 
hours 
3 mos 
 
 
 
3 yr 
FIM NCSE 
Initial FIM 
Age 
 
NIHSS 
Age 
Initial FIM 
 
Lesion volume 
NIHSS 
 
 
Cognitive status  
Lesion volume 
R2=0.42 
 
Rost  
2008 
629 Hemorrhagic H, ? 90 days GOS ≥4 ICH volume (<30, 30-60, >60 
cm3) 
Age (<70, 70-79, ≥80 yr)  
GCS (≥9, ≤8) 
ICH location (lobar, deep, 
infratentorial)  
Prior cognitive impairment * 
 
Gender 
Hypertension 
Diabetes 
Coronary artery disease 
Warfarin use 
 
c-statistic 
0.88 
Hallevi  
2009 
1798 Ischemic H, <7 days 3 mos mRS ≤2 Model, mRS 3 at day 7, 
NIHSS total  
NIHSS (≤4, >4) 
Number of risk factors (≤2, 
>2) 
Age (≤70, >70) 
 
Model, mRS 3 at day 7, 
items NIHSS  
Number of risk factors (≤2, 
>2) 
NIHSS motor arm (≤1, >1)  
Age (≤70, >70) 
NIHSS language (0, >0) 
 
Model, mRS 4 at day 7, 
NIHSS total  
NIHSS (≤8, >8) 
Age (≤70, >70) 
Gender 
 
Model, mRS 4 at day 7, 
items NIHSS  
NIHSS motor leg  
Age (≤70, >70) 
NIHSS visual fields  
NIHSS facial palsy  
Gender 
NIHSS dysarthria  
 
Model, mRS 5 at day 7, 
NIHSS total  
NIHSS (≤17, >17) 
Age (≤70, >70) 
rTPA  
 
Model, mRS 5 at day 7, 
items NIHSS  
NIHSS motor leg (≤2, >2) 
Age (≤70, >70) 
rTPA  
NIHSS dysarthria (0, >0) 
 
 
 
 
 
 
 
NIHSS level of 
consciousness  
NIHSS facial palsy  
NIHSS dysarthria  
 
 
 
rTPA 
Risk factors 
 
 
 
 
rTPA 
Number of risk factors 
NIHSS consciousness  
NIHSS gaze  
NIHSS motor arm  
NIHSS language  
NIHSS extinction  
 
 
 
 
Congestive heart disease  
 
 
 
 
 
NIHSS facial palsy  
NIHSS visual fields  
NIHSS motor arm  
NIHSS sensory  
NIHSS extinction  
R2=0.28 
 
 
 
 
 
R2=0.28 
 
 
 
 
 
 
R2= 0.22 
 
 
 
 
 
R2= 0.25 
 
 
 
 
 
 
 
 
 
R2=0.22 
 
 
 
 
 
R2=0.25 
Stone  
1993 
171 
 
Ischemic, 
hemorrhagic, 
hemispheric 
H, <72 
hours 
3, 6 mos BI  
0-14, 15-19, 
20 
Age 
Visual Neglect Recovery 
Index 
Initial MI 
 
Hemi inattention 
Visual extinction 
Sensory extinction 
Allesthesia 
Anosognosia 
Level of consciousness 
Gaze paresis 
Visual field defect 
Proprioception 
Acc 0.75 
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 Chua  
1995 
51 
 
Ischemic, 
cortical 
H, < 24 
hours  
3 mos BI >12 APS CNS 24 hours 
BI day 7 
Age 
 
Sens 0.82 
Spec 0.97 
Macciocchi 
1998 
327 
 
Ischemic, 
MCA 
?, 7-10 days  
 
3 mos  BI >60 Lesion side (left, right) 
Cortical lesion (cortical, 
other) 
Prior stroke * 
UNSS  
Age (70 vs. 60, 80 vs. 60 yr) 
 
Comorbid medical 
disorders 
 
Adams  
2003 
 
1281 Ischemic H, <24 
hours 
3 mos GOS 1/ BI 
≥19 
 
 
 
 
 
 
GOS ≤2/ BI 
≥12 
Baseline NIHSS 
Small-artery occlusion * 
NIHSSsmall-artery 
occlusion 
Age 
Race 
Prior stroke * 
 
Baseline NIHSS 
Small-artery occlusion * 
NIHSSsmall-artery 
occlusion 
Age 
Race 
 
Gender  
 
 
 
 
 
 
 
Gender 
Prior stroke 
 
 
 
Studenski 
2004 
236 Ischemic, 
hemorrhagic 
H, 8 days 3, 6 mos BI ≥95 Comorbidity burden (CDI) 
(≤1, 2, ≥3 domains) 
Baseline NIHSS (<6, ≥6) 
Age  
 
  
Colantonio 
1996 
63 
 
Ischemic, 
hemorrhagic, 
>65 yr 
C, ? 6 mos  Katz Scale Pre-stroke physical function 
(Katz scale: 0, 1+) 
Race (white, nonwhite) 
Stroke severity (0-1, 2-3, 4-
5) 
Prior gross mobility 
Age 
Gender 
Years of education 
Housing 
Comorbidity 
Prior cognitive 
impairment 
Complications  
 
R2=0.32 
 
Di Carlo 
1999 
4499 
 
Ischemic, 
hemorrhagic, 
first-ever 
H, ? 
 
3 mos BI <15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mRS ≥2 
Model, Total 
Urinary incontinence * 
Paralysis * 
Swallowing problems * 
Hypertension * 
 
Model, <80 yr 
Urinary incontinence * 
Swallowing problems * 
Paralysis * 
Diabetes * 
Atrial fibrillation * 
Hypertension * 
 
Model, ≥80 yr 
Urinary incontinence * 
Paralysis * 
Prior institutionalization * 
Swallowing problems * 
 
Model, Total 
Urinary incontinence * 
Paralysis * 
Prior institutionalization * 
Swallowing problems * 
Aphasia * 
Myocardial infarction * 
Diabetes * 
Hypertension * 
 
Model, <80 yr 
Urinary incontinence * 
Paralysis * 
Myocardial infarction * 
Swallowing problems * 
Aphasia * 
Diabetes * 
Hypertension * 
 
Model, ≥80 yr 
Prior institutionalization * 
Myocardial infarction * 
Urinary incontinence * 
 
Prior institutionalization 
Atrial fibrillation 
Diabetes 
 
 
 
Prior institutionalization 
 
 
 
 
 
 
 
Hypertension 
Atrial fibrillation 
Diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prior institutionalization 
 
 
 
 
 
 
 
 
Hypertension 
Diabetes 
Myocardial infarction 
Aphasia 
Swallowing problems 
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 Shah  
2005 
53 
 
Ischemic, 
hemorrhagic, 
thalamic 
?, <6 days 3 mos BI ≥12 Type of hematoma * 
CNS (<3, ≥3) 
 
Size of hematoma 
Diabetes  
GOS 
Pupillary asymmetry 
MEP 
SEP  
 
 
Daviet  
2006 
156 
 
Ischemic, 
hemorrhagic, 
first-ever, 
hemispheric 
H, <24 
hours 
1 yr BI 
 
 
 
 
 
Initial BI † 
∆ BI day 2-15 
Disorders executive function 
* 
Previous neurological 
impairment * 
 
Myocardial infarct 
Coma 
Hemianopsia 
Motor impairment day 2 
Hemineglect 
Astéreoagnosie 
MMSE day 15 
Incontinence day 15 
Swallowing day 2 
Age 
 
 
Horner  
2003 
598  
 
Ischemic, 
hemorrhagic 
H, ? 1 yr mRS  Model 1, effect race 
Blacktime 
Time (log function) 
 
Model 2, effect race + 
covariates 
Discharge to nursing home 
or other institution 
Lives alone * 
Inpatient treatment by 
neurologist * 
Time (log function) 
CNS 
Days to rehabilitation 
initiation 
Blackdays to 
rehabilitationtime 
Days to rehabilitationtime 
Age 
 
Black 
 
 
 
Gender 
Marital status 
Living situation at 
discharge 
Income level 
Stroke etiology 
Mental status 
Time from onset to 
admission 
 
Clavier  
1994 
177 
 
Ischemic, 
lacunar 
H, ? 
 
1 yr 
35 mos 
BI 
 
Type lacunar syndrome  
- sensorimotor * 
- pure motor * 
Diabetes * 
Age (<70, >70 yr) 
History of stroke/TIA * 
 
Cigarette smoking 
Ischemic heart disease 
Hypertension 
Cardiomegaly 
Dyslipedemia 
Number of lacunes on 
MRI  
Gender 
 
ROC curve 
Robinson 
1999 
50 
 
Ischemic, 
hemorrhagic 
H, 9.9 days 
 
12-24 mos JHFI Pre-stroke financial security 
† 
Adequacy home and 
neighborhood 
Relationship with significant 
other 
NIHSS 
 
Relationship with 
children 
Family relationship 
Home and family 
responsibilities 
Work experience 
Social activities 
Spiritual beliefs 
Living environment 
Health and illness 
experiences 
 
R2=0.53 
Weir  
2005 
2709 Ischemic, 
hemorrhagic 
H, 7 days 6 mos mRS  Age † 
Prior ADL-independency * 
Pre-stroke living alone * 
GCS verbal * 
Able to lift both arms * 
Able to walk unaided * 
 
Gender 
Diabetes  
Ischemic heart disease 
Stroke type (ischemic, 
hemorrhagic) 
Stroke onset in hospital 
Admission GCS eye  
Admission GCS motor  
High systolic blood 
pressure 
Urinary incontinence 
 
 
Handschu 
2009 
159 ? H, <24 
hours after 
admission 
3 mos mRS NIHSS  Age 
Gender 
R2=0.37 
Σ 25843        
H, Hospital-based; ?, unclear; mos, Months; mRS, Modified rankin scale; *, dichotomized i.e. yes/ no; GCS, Glasgow coma scale; CIVIC, 
Consortium for the investigation of vascular impairment of cognition; CT, Computed tomography scan; TIA, Transient ischemic attack; TACI, total 
anterior circulation syndrome; LACI, lacunar syndrome; rTPA, Recombinant tissue plasminogen activator; AUC, Area under the curve; CNS, 
Canadian neurological scale; Acc, Accuracy; Sens, Sensitivity; Spec, Specificity; BI, Barthel index; DWI, Diffusion-weighted magnetic resonance 
imaging; NIHSS, National institutes of health stroke scale; MAE, Mean absolute error; TOAST, Trial of ORG 10172 in Acute Stroke Treatment; C, 
community-based; OHS, Oxford handicap scale; SE, Standard error; †, Non hierarchical order; MCA, Middle cerebral artery; yr, Year; MRI, 
Magnetic resonance imaging; MI, Motricity index; M, Motor; MS, Motor-sensitive; MSH, Motor-sensitive with hemianopsia; SF-36, Short-form (36) 
health survey; GDS, Geriatric depression scale; HAND, Grips strength using multi myometermotor evoked potentials (MEP); HL statistic, 
Hosmer-Lemeshow goodness of fit statistic; FIM, Functional independence measure; TCT, Trunk control test; ECG, Electrocardiograph; GOS, 
Glasgow outcome scale; OSCP, Oxfordshire Community Stroke Project; ADL, Activities of daily living; SSS, Scandinavian stroke scale; CCA-IMT, 
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Common carotid artery intima-media thickness; NCSE, Neurobehavioral cognitive status examination; ICH, Intracranial hemorrhage; APS, Allan’s 
prognostic score; UNSS, Unified neurological stroke scale; CDI, Comorbidity disease index; SEP, Somatosensory evoked potentials; ∆, Change; 
MMSE, Mini-mental state examination; ROC, Receiver operating curve; JHFI, Johns Hopkins functioning inventory 
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  Table III. Risk of bias assessment of included prognostic studies 
 Study design Study attrition Predictor measurement Outcome measurement Statistical analysis Clinical 
performance/validity 
 
Reference D1 D2 D3 D4 D5 D6 A1 A2 A3 A4 P1 P2 P3 P4 O1 O2 O3 O4 O5 S1 S2 S3 S4 S5 C1 C2 C3 Total (/27) 
High quality studies                             
Reid 2010 1 1 1 1 0 0 1 1 0 ? 1 1 1 1 1 1 1 1 1 ? 1 1 1 1 1 1 1 22 
Fiorielli 1995 1 1 1 0 1 1 1 1 1 1 1 ? 0 1 1 1 1 1 1 1 1 1 1 0 1 ? 1 22 
Johnston 2007 1 1 1 1 1 1 1 ? ? 0 1 1 1 1 1 1 ? 1 1 0 1 0 1 1 1 1 1 21 
Weimar 2006 1 1 1 1 1 1 0 1 0 1 1 ? ? 1 1 1 0 1 1 1 1 0 1 1 1 ? 1 20 
Sato 2008 1 1 1 1 1 0 1 1 1 1 1 1 ? 1 1 1 1 1 1 0 0 0 1 1 1 ? ? 20 
Weimar 2002 1 1 1 0 1 0 1 1 0 0 1 0 1 1 1 1 ? 1 1 1 1 0 1 1 1 1 1 20 
 
                            
Low quality studies                             
Counsell 2002 1 1 1 1 1 ? 1 1 1 1 1 1 ? ? 1 1 ? 1 1 1 ? 0 1 ? 1 ? 1 19 
Schiemanck 2006 1 1 1 1 ? 0 1 1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 1 ? 1 ? ? 19 
Appelros 2003 1 1 1 1 ? 0 1 1 1 1 1 ? 0 1 1 1 1 1 1 0 1 1 1 1 ? ? ? 19 
Sánchez-Blanco 1999 1 1 1 1 0 1 1 1 1 1 1 1 ? 1 1 1 0 1 1 1 0 0 1 0 1 ? ? 19 
Baird 2001 1 1 ? ? 1 0 1 1 1 1 1 1 ? 1 1 1 1 1 1 ? 0 0 1 0 1 ? 1 18 
Lai 2002 1 1 ? 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 1 0 1 1 ? ? ? 18 
Woldag 2006 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 ? 1 0 0 0 1 1 ? ? 18 
Acciarresi 2006 1 1 1 1 ? 0 1 1 1 1 1 ? ? 1 1 1 ? 1 1 0 1 1 1 ? ? ? ? 17 
Yoo 2008 1 1 1 1 1 0 0 1 0 ? 1 1 ? 1 1 1 0 1 1 ? 1 0 1 1 1 ? ? 17 
Lee 2009 1 1 ? 1 1 0 1 1 0 0 1 1 1 1 1 1 ? 1 1 1 1 0 1 ? ? ? ? 17 
Duarte 2010 1 1 1 1 1 1 1 1 0 0 1 1 ? 1 1 1 1 1 1 ? ? 0 0 0 1 ? ? 17 
Fullerton 1988 ? 1 ? 1 1 0 1 1 1 1 1 0 1 0 1 0 1 1 0 1 1 0 0 1 1 ? ? 16 
Daverat 1991 ? 1 ? 1 1 1 1 1 1 1 1 0 ? 1 1 1 ? 1 1 ? 1 0 1 0 ? ? ? 16 
Taub 1994 1 1 ? 1 1 0 0 1 0 0 1 0 ? 1 1 1 1 1 1 1 1 1 0 0 1 ? ? 16 
Johnston 2000, 2003 1 1 ? 0 1 0 1 ? ? 0 1 ? ? 1 1 1 ? 1 1 0 1 0 1 1 1 1 1 16 
Liu 2007 1 1 ? 0 1 0 1 1 0 1 1 ? 0 1 1 1 0 0 1 1 1 1 1 ? 1 ? ? 16 
Protopsaltis 2009 0 ? 1 1 ? 1 1 1 1 1 1 0 ? 1 1 1 1 0 1 0 1 0 ? 1 1 ? ? 16 
Shen 2010 1 1 1 1 1 0 0 ? 0 0 1 1 1 1 1 1 1 1 1 ? 1 0 1 ? ? ? ? 16 
Franke 1992 1 1 ? 1 ? 0 1 1 1 1 1 1 0 1 1 1 ? 1 1 ? 1 0 0 0 ? ? ? 15 
Censori 1993 1 1 ? 1 1 0 1 1 1 1 1 ? ? ? 1 1 ? 1 0 1 1 0 1 0 ? ? ? 15 
FOOD collaboration 2003 1 1 ? 1 1 ? 1 1 1 0 ? ? ? 1 1 1 ? 1 1 0 1 ? 1 1 ? ? ? 15 
Sobrino 2007 ? 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1 0 ? 0 1 ? ? ? ? 15 
Misra 1996 ? 1 1 1 ? 0 1 1 1 0 1 0 0 1 1 1 ? 1 1 1 0 0 1 0 ? ? ? 14 
Tilling 2001 1 ? ? 0 ? 1 1 ? 1 0 1 0 ? 1 1 1 1 1 1 1 1 ? ? 0 ? ? 1 14 
Ellul 2004 ? 1 1 1 1 0 1 1 0 0 1 1 ? 1 1 1 0 1 0 0 1 ? 1 0 ? ? ? 14 
Hinkle 2006, 2010 ? 1 1 1 ? ? 0 ? 0 ? 1 0 ? 1 1 1 1 1 1 1 1 0 1 ? 1 ? ? 14 
Rost 2008 1 1 1 0 0 0 1 0 0 ? 1 ? ? 1 1 1 ? 1 1 ? 1 0 1 0 1 ? 1 14 
Hallevi 2009 1 1 ? 0 1 ? 1 1 0 0 1 0 ? 1 1 1 0 1 1 0 1 0 1 0 1 ? ? 14 
Stone 1993 ? 1 ? 1 1 0 1 1 0 0 1 0 ? ? 1 1 1 1 1 1 0 0 ? ? 1 ? ? 13 
Chua 1995 0 1 ? 1 1 0 1 1 0 0 1 ? ? ? ? 1 1 1 0 0 1 1 1 ? 1 ? ? 13 
Macciocchi 1998 ? 1 ? 1 1 1 1 0 0 0 1 1 ? ? 1 1 ? 1 1 ? 1 0 1 ? ? ? ? 13 
Adams 1999 1 1 ? 0 1 ? 1 1 0 0 1 1 ? 0 1 1 ? 1 0 0 1 0 1 1 ? ? ? 13 
Studenski 2004 1 ? ? 1 1 0 1 0 0 0 1 1 ? 1 1 1 1 1 1 0 1 0 ? ? ? ? ? 13 
Colantonio 1996 1 1 1 1 1 0 1 ? 0 1 1 0 ? ? 1 0 ? 0 ? 0 0 1 1 0 1 ? ? 12 
Di Carlo 1999 ? 1 ? 0 ? 1 1 0 0 0 1 0 ? ? 1 1 ? 1 1 1 1 0 1 1 ? ? ? 12 
Shah 2005 ? ? 1 1 1 0 1 1 0 0 1 ? ? ? 1 1 ? 1 1 1 0 0 1 0 ? ? ? 12 
Daviet 2006 1 1 ? 1 1 0 0 1 0 0 1 1 ? ? 1 1 1 1 0 ? 1 0 0 ? ? ? ? 12 
Horner 2003 1 ? ? 1 0 1 1 ? 0 ? 1 ? ? 1 1 1 ? 1 0 0 1 0 1 ? ? ? ? 11 
Clavier 1994 ? ? ? 1 ? 0 0 ? 0 0 1 0 ? 1 1 1 ? 1 1 ? ? 0 1 0 1 ? ? 9 
Robinson 1999 ? ? ? 1 ? 0 0 ? 0 1 ? 0 ? 1 1 0 1 1 1 0 0 0 0 1 1 ? ? 9 
Weir 2005 1 1 ? 0 0 0 0 0 1 0 ? ? ? 1 1 1 ? 1 0 0 1 0 0 1 ? ? ? 9 
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Handschu 2009 ? ? ? 1 1 0 0 0 0 0 ? 0 0 0 ? 1 0 1 0 0 1 0 0 0 1 ? ? 6 
%  satisfied (1 point) 69 83 48 77 67 27 77 67 33 38 92 42 19 75 96 94 49 94 75 38 71 17 73 35 56 8 21 17* 
D, Study design; A, Study attrition; P, Predictor measurement; O, Outcome measurement; S, Statistical analysis; C, Clinical performance/validity; 1, Positive; 0, Negative; ?, Partial/unknown; D1, Source population and 
recruitment; D2, Inclusion and exclusion criteria; D3, Important baseline key characteristics of study sample; D4, Prospective design; D5, Inception cohort; D6, Information about treatment; A1, Number of loss to follow-up; A2, 
Reasons for loss to follow-up; A3, Methods dealing with missing data; A4, Comparison completers and non-completers; P1, Definition of predictors; P2, Measurement of predictors reliable and valid; P3, Coding scheme and cut-
off points; P4, Data presentation; O1, Outcome(s) defined; O2, Measurement of outcome(s) reliable and valid; O3, Coding scheme and cut-off points described; O4, Appropriate end-points of observation; O5, Data presentation; 
S1, Strategy for model building described; S2, Sufficient sample size; S3, Presentation univariable analysis; S4, Presentation multivariable analysis; S5, Continuous predictors; C1, Clinical performance; C2, Internal validation; 
C3, External validation; *, Median 
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Table IV. Evidence synthesis of variables measured early after stroke which are not predictive for 
outcome of ADL ≥3 months poststroke, according to the ICF classification 
Variable Level of 
evidence 
Body structures 
 
Ischemic/hemorrhagic II 
Topographic stroke subtype (OCSP) IV 
· LACI II 
· TACI II 
Imagine variables  
· Number focal lesions II 
· Ventricular bleeding and/or 
hydrocephalus 
II 
· Any computed tomography abnormality III 
· Acute infarct III 
· Acute infarct or hemorrhage III 
· Posterior circulation III 
· Subcortical IV 
· Entire middle cerebral artery IV 
· Infratentorial  II 
· Putamen, thalamus, lobe IV 
TimeDWI stroke volume III 
Stroke etiology (TOAST) II 
· Small vessel occlusion IV 
· Cardioembolism IV 
· Undetermined causes IV 
NIHSSsmall vessel occlusion IV 
Days to MRI  IV 
IMT IV 
Carotid stenosis IV 
  
Body functions 
 
· Consciousness (e.g. GCS) II 
· GCS eye IV 
· GCS motor IV 
· Paresis  
· Leg paresis IV 
· ∆ GripstrengthMEP IV 
· MEP IV 
· SEP IV 
· Hemianopsia IV 
· Gaze palsy IV 
· Facial palsy IV 
· Brain stem function IV 
· Sensory function IV 
· Vital IV 
· Proprioception IV 
· Dysarthria II 
· Cognitive deficit  
· Neglect IV 
· Spatial orientation IV 
· Apraxia IV 
· Anosognosia IV 
· Astéreoagnosie IV 
· Extinction IV 
· Visual extinction IV 
· Sensory extinction IV 
· Allesthesia IV 
· Comprehension of speech IV 
· Functional/oral expression IV 
· Denial IV 
∆ Stroke severity admission – day 7 IV 
Complications IV 
Mental status IV 
Urinary incontinence IV 
Renal failure IV 
  
Activity and participation 
 
Sitting balance IV 
Gait  
· Walking/balance IV 
· Walk without assistance III 
Arm function IV 
  
Variable Level of 
evidence 
Personal factors 
 
Gender I 
Pre-stroke disability II 
Comorbidity and riskfactors IV 
· Number of riskfactors IV 
· Prior stroke/TIA III 
· Prior TIA IV 
· Neurological impairment IV 
· Atrial fibrillation I 
· Hypertension IV 
· Myocardial infarction IV 
· Ischemic heart disease IV 
· Heart failure IV 
· Congestive heart disease IV 
· Cardiogmegaly IV 
· Malignancy IV 
· Current smoker IV 
· Peripheral vascular disease IV 
· Peripheral atherosclerosis IV 
· Cervical bruit IV 
· Health and illness experiences IV 
Cardiac, blood and urine variables  
· Systolic blood pressure IV 
· ECG changes IV 
· High hemoglobulin level IV 
· Anemia IV 
· Glucose IV 
· High systolic blood pressure IV 
· Apoplectic onset IV 
· Hematocrit IV 
· Erythrocyte sedimentation rate IV 
· Pupillary asymmetry IV 
· Cholesterol IV 
· Serum albumin IV 
· Fibrinogen IV 
· C-reactive protein IV 
Marital status IV 
Relationship IV 
Family support IV 
Relationship with children IV 
Family relationship IV 
Home and family responsibilities IV 
Social activities IV 
Years of education IV 
Employed IV 
Work experience IV 
Income level IV 
Nutrition  
· Initial undernutrition  IV 
· Overweight IV 
· Insufficient diet IV 
· External feed IV 
Body mass index IV 
Ethnic origin IV 
Black IV 
Spiritual beliefs IV 
  
Environmental factors 
 
Presenting <3 hours III 
Examined <2 days IV 
Stroke onset in hospital IV 
Platelet count IV 
Participation drug trial IV 
Warfarin use IV 
Time from onset to admission IV 
Length of hospital stay IV 
Acute hospital discharge IV 
District of residence IV 
Living environment IV 
Living situation at discharge IV 
Housing IV 
 I, Strong evidence; II, Moderate evidence; III, Limited evidence; IV, Insufficient/no evidence; OCSP, Oxfordshire community stroke project; LACI, 
lacunar syndrome; TACI, total anterior circulation syndrome; DWI, Diffusion-weighted imaging; TOAST, Trial of ORG 10172 in acute stroke 
treatment ; GCS, Glasgow coma scale; MEP, Motor evoked potentials; SEP, sensory invoked potentials; ∆, Change; TIA, Transient ischemic 
attack; ECG, Electrocardiograph 
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